Barriers to atrial fibrillation ablation during mitral valve surgery
- PMID: 33840467
- PMCID: PMC8446105
- DOI: 10.1016/j.jtcvs.2021.03.039
Barriers to atrial fibrillation ablation during mitral valve surgery
Abstract
Background: Nearly 40% of patients with atrial fibrillation (AF) undergoing mitral valve surgery do not receive concomitant ablation despite societal guidelines. We assessed barriers to implementation of this evidence-based practice through a survey of cardiac surgeons in 2 statewide quality collaboratives.
Methods: Adult cardiac surgeons across 2 statewide collaboratives were surveyed on their knowledge and practice regarding AF ablation. Questions concerning experience, clinical practice, case scenarios, and barriers to implementation were included.
Results: Among 66 respondents (66 of 135; 48.9%), the majority reported "very comfortable/frequently use" cryoablation (53 of 66; 80.3%) and radiofrequency (55 of 66; 83.3%). Only 12.1% (8/66) were not aware of the recommendations. Approximately one-half of the respondents reported learning AF ablation in fellowship (50.0%; 33 of 66) or attending courses (47.0%; 31 of 66). Responses to clinical scenarios demonstrated wide variability in practice patterns. One-half of the respondents reported no barriers; others cited increased cross-clamp time, excessive patient risk, and arrhythmia incidence as obstacles. Desired interventions included cardiology/electrophysiology support, protocols, pacemaker rate information, and education in the form of site visits, videos and proctors.
Conclusions: Knowledge of evidence-based recommendations and practice patterns vary widely. These data identify several barriers to implementation of concomitant AF ablation and suggest specific interventions (mentorship/support, protocols, research, and education) to overcome these barriers.
Keywords: atrial fibrillation; barriers; concomitant ablation; implementation science.
Copyright © 2021 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
Comment in
-
Commentary: What will make surgeons do more atrial fibrillation ablations?J Thorac Cardiovasc Surg. 2023 Feb;165(2):659-660. doi: 10.1016/j.jtcvs.2021.04.012. Epub 2021 Apr 20. J Thorac Cardiovasc Surg. 2023. PMID: 33958194 No abstract available.
-
Commentary: Navigating a MAZE of implementation science for surgical atrial fibrillation ablation.J Thorac Cardiovasc Surg. 2023 Feb;165(2):660-661. doi: 10.1016/j.jtcvs.2021.04.029. Epub 2021 Apr 18. J Thorac Cardiovasc Surg. 2023. PMID: 33972112 No abstract available.
References
-
- Badhwar V, Rankin JS, Damiano RJ Jr., Gillinov AM, Bakaeen FG, Edgerton JR, et al. The Society of Thoracic Surgeons 2017 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation. Ann Thorac Surg. 2017;103:329–341. - PubMed
-
- Damiano RJ, Badhwar V, Acker MA, Veeragandham RS, Kress DC, Robertson JO, et al. The CURE-AF trial: A prospective, multicenter trial of irrigated radiofrequency ablation for the treatment of persistent atrial fibrillation during concomitant cardiac surgery. Heart Rhythm. 2014;11:39–45. - PubMed
-
- Badhwar V, Rankin JS, Ad N, Grau-Sepulveda M, Damiano RJ, Gillinov AM, et al. Surgical Ablation of Atrial Fibrillation in the United States: Trends and Propensity Matched Outcomes. Annals of Thoracic Surgery. 2017;104:493–500. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
